Value Bridge — SANTA CLARA VALLEY MEDICAL CENTER
Current $-128M → Target $-71M (+$56.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-127.6M
Current EBITDA
$-71.2M
Target EBITDA
+$56.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$12.8M
Payer Mix Optimization
$30.6M
Cost to Collect Reduction
$10.2M
Clean Claim Improvement
$7.7M
Volume & Rate Growth
$51.0M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-128M to $-71M. The highest-impact lever is Volume & Rate Growth at $20.4M probability-weighted.
IC talking point: "We see $56M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $620M in equity value creation."